Use of Preoperative FDG PET/CT and Survival of Patients with Resectable Non–Small Cell Lung Cancer

ASIA unversity > 醫學暨健康學院 > 食品營養與保健生技學系 > 期刊論文 > Item 310904400/115237

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://asiair.asia.edu.tw/ir/handle/310904400/115237

题名:	Use of Preoperative FDG PET/CT and Survival of Patients with Resectable Non–Small Cell Lung Cancer
作者:	Che, Wan-Ming;Chen, Wan-Ming;Che, Mingchih;Chen, Mingchih;Hs, Jeng-Guan;Hsu, Jeng-Guan;Tian-Shyug, L;Lee, Tian-Shyug;Sh, Ben-Chang;Shia, Ben-Chang;吳思遠;Wu, Szu-Yuan
贡献者:	醫學暨健康學院食品營養與保健生技學系
日期:	2022-06-01
上传时间:	2023-03-29 01:05:52 (UTC+0)
出版者:	亞洲大學
摘要:	Use of preoperative PET/CT was associated with lower risk of death in patients with stage IIIA–IIIB non–small cell lung cancer. Background The added value of preoperative PET/CT for the overall survival of patients with resectable non–small cell lung cancer (NSCLC) is unknown. Purpose To investigate the association of the use of preoperative PET/CT on survival of patients with resectable stage I–IIIB NSCLC. Materials and Methods In this retrospective study, patients with resectable stage I–IIIB NSCLC who underwent thoracic surgery from January 1, 2009, to December 31, 2018, from the Taiwan Cancer Registry were included. The last follow-up date was December 31, 2019. Patients were categorized into two groups according to whether they underwent preoperative metabolic imaging with fluorine 18 fluorodeoxyglucose PET/CT. Patients who did not undergo preoperative imaging were used as the control group. The primary outcome of interest was all-cause mortality. Patients in both groups were propensity score matched at a ratio of 1:1. Matching variables used were sex, age, histologic findings, American Joint Committee on Cancer clinical stage, cT stage, cN stage, current and past smoker history, adjuvant chemotherapy, adjuvant chemoradiation, Charlson comorbidity index, and hospital type. Survival curves were generated using the Kaplan-Meier method and compared using the log-rank test. Results In the matched cohort, 6754 patients (3349 men, mean age ± SD: 64 years ± 11) underwent PET/CT and 6754 did not (3362 men, mean age: 64 years ± 11). In adjusted analysis, patients with stage IIIA or IIIB NSCLC and preoperative PET/CT had a lower risk of death versus those without PET/CT (for stage IIIA: hazard ratio [HR] = 0.90 [95% CI: 0.79, 0.94], P = .02; for stage IIIB: HR = 0.80 [95% CI: 0.71, 0.90], P < .01). There was no improvement in a lower risk of death for patients with stage I–II NSCLC (after multivariable adjustment, the HR was 1.19 [95% CI: 0.89, 1.30], P = .65). Conclusion Use of preoperative PET/CT was associated with lower risk of death in patients with stage IIIA–IIIB non–small cell lung cancer compared with those without preoperative PET/CT.
显示于类别:	[食品營養與保健生技學系] 期刊論文

文件中的档案:

档案	描述	大小	格式	浏览次数
index.html		0Kb	HTML	93	检视/开启

在ASIAIR中所有的数据项都受到原著作权保护.

数据加载中.....